In a 26-year-old woman with polymenorrhea every two weeks for one year, who has not responded to the combined oral contraceptive Nexstellis (ethinyl estradiol/levonorgestrel) and has a normal pelvic ultrasound, what is the next step in management?

Further Management: Switch to Alternative Hormonal Contraceptive or Consider Levonorgestrel-IUD

Since Nexstellis (a combined oral contraceptive) has failed to control your polymenorrhea after one year of use and structural pathology has been ruled out with normal pelvic ultrasound, you should switch to an alternative combined hormonal contraceptive formulation or consider a levonorgestrel-releasing intrauterine device (LNG-IUD) as first-line options.

Algorithmic Approach to Management

Step 1: Rule Out Underlying Pathology (Already Completed)

You've appropriately completed:

• Normal pelvic ultrasound (structural causes excluded) 1
• Consider checking: thyroid function, prolactin, pregnancy test, coagulation studies if not already done 1, 2

Step 2: Optimize Current Hormonal Therapy or Switch

Since you're already on Nexstellis without effect, consider these options in order:

Option A: Switch to Continuous/Extended Regimen Combined Hormonal Contraceptive

• Try continuous dosing (no hormone-free interval) of a different combined hormonal contraceptive formulation 3, 1
• Rationale: Continuous regimens suppress endometrial proliferation more effectively and reduce bleeding episodes 4, 5, 6
• Specific recommendation: Use a low-dose ethinyl estradiol/levonorgestrel formulation (20 mcg EE/90-100 mcg LNG) taken continuously without breaks 4, 5
• Important caveat: Expect breakthrough bleeding during first 3-6 months of continuous use; this typically decreases with continued use 3, 1, 3

Option B: Levonorgestrel-Releasing IUD (LNG-IUD)

• Highly effective for managing abnormal uterine bleeding with excellent long-term amenorrhea rates 1
• Provides both contraception and therapeutic benefit for bleeding control
• May be preferred if oral compliance is an issue or if patient desires long-acting reversible contraception

Option C: Alternative Combined Hormonal Contraceptive Delivery Systems

• Transdermal patch (levonorgestrel/ethinyl estradiol) 7, 8
• Vaginal ring 3
• These may improve compliance and provide more stable hormone levels

Step 3: If Hormonal Methods Continue to Fail

If bleeding persists despite optimized hormonal therapy:

Medical Treatment Options 1, 3:

• NSAIDs (ibuprofen, mefenamic acid) for 5-7 days during bleeding episodes
• Tranexamic acid 1-1.5g three times daily for 5 days during menses (antifibrinolytic)
• These can be used adjunctively with hormonal contraception

Further Evaluation 1:

• Endometrial biopsy if age >45 years or risk factors for endometrial hyperplasia/cancer
• Consider hysteroscopy if imaging inadequate or persistent unexplained bleeding
• Evaluate for bleeding disorders (von Willebrand disease, platelet dysfunction) - particularly important in young women with heavy bleeding since menarche 2

Step 4: Surgical Options (If Medical Management Fails)

Reserved for refractory cases 9:

• Endometrial ablation
• Hysterectomy (definitive but last resort in young woman)

Key Clinical Pearls

Common Pitfalls to Avoid:

1. Don't assume all BCPs are equivalent - Nexstellis contains estetrol (not ethinyl estradiol), which may have different endometrial effects than traditional formulations 10
2. Don't dismiss breakthrough bleeding too quickly - If switching to continuous regimen, counsel patient that breakthrough bleeding for 3-6 months is expected and doesn't indicate failure 3, 1
3. Don't forget to assess compliance - Inconsistent pill-taking can cause irregular bleeding that mimics treatment failure 3

Medication Interactions to Consider:

• Certain antibiotics, anticonvulsants, and St. John's Wort can reduce contraceptive efficacy 10
• Verify no interfering medications before labeling as treatment failure

Specific Recommendation for This Patient

Given your age (26), normal anatomy, and failed response to Nexstellis, I recommend:

1. First choice: Switch to continuous-regimen low-dose combined oral contraceptive (20 mcg ethinyl estradiol/90-100 mcg levonorgestrel) taken daily without hormone-free intervals 4, 5, 6

   • Counsel about expected breakthrough bleeding for first 3-6 months
   • Use backup NSAIDs during bleeding episodes if needed

2. Alternative first choice: LNG-IUD insertion 1

   • Particularly if long-acting contraception desired
   • Excellent bleeding control with high amenorrhea rates over time

3. If both fail: Formal evaluation for bleeding disorders and consideration of endometrial sampling depending on risk factors 2